Codoxo
PrivateLast Round
Series C
Dec 17, 2025
Total Funding Raised
$64.58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Codoxo operates in Healthcare & Life Sciences and is based in Duluth, Georgia. Its latest recorded funding round was a Series C round in December 2025.
Codoxo is a healthcare AI company that provides a unified cost containment platform using generative AI to identify and reduce fraud, waste, and abuse for healthcare payers, government agencies, and pharmacy benefit managers.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Revenue Cycle, Compliance & Risk, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Codoxo Comparables
Compare Codoxo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alivia Analytics | 89% | |
| Alaffia Health | 88% | |
| Healthcare Fraud Shield | 88% |
For institutional investors. Book with your work email.
Codoxo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 17, 2025 | ||||
| Series B | Feb 3, 2022 | ||||
| Series A | Jul 2, 2020 | ||||
| Grant | Aug 15, 2018 | ||||
| Seed | Jun 12, 2017 | ||||
Accelerator | Oct 31, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Codoxo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Service Provider Capital | Seed |
| 111 West Capital | Series B, Series C |
| The Wallace H. Coulter Foundation | Grant |
| Brewer Lane Ventures | Series B, Series C, Series A |
| Georgia Research Alliance | Series B, Seed, Series A |
| QED Investors | Series C, Series A, Series B |
| Mosley Ventures | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
Launched AI-driven Deepfake Detection tool for fraud prevention.
- Mar 11, 2026
Launched Generative AI-driven Unified Cost Containment Platform for healthcare payers.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 27, 2026
Codoxo and UnitedHealth Group present innovative strategies for uncovering healthcare fraud at NHCAA 2026.
- recognized_asSep 29, 2026
In Georgia on Sep 29th '26, Codoxo is included in the second edition of TIME and Statista Inc.'s World's Top HealthTech Companies 2026 ranking, which recognizes the top 500 health-tech companies advancing healthcare through technology.
- attends_eventSep 2, 2026
Codoxo's Point Zero Payment Integrity solution is named the winner in the AI Innovation in Regulatory & Compliance category of the 2026 Fierce AI Innovation Awards in Georgia on Sep 2nd '26.
- recognized_asSep 2, 2026
Codoxo's Point Zero Payment Integrity solution is named the winner in the AI Innovation in Regulatory & Compliance category of the 2026 Fierce AI Innovation Awards after selection by expert judges in Georgia on Sep 2nd '26.
- recognized_asSep 2, 2026
Codoxo's Point Zero Payment Integrity solution is named the winner in the "AI Innovation in Regulatory & Compliance" category at the 2026 Fierce AI Innovation Awards after review by expert judges in Georgia on Sep 2nd '26.
For institutional investors. Book with your work email.
Codoxo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Codoxo's valuation, stock price, and market status.
Is Codoxo a public or private company?
Codoxo is a private company.
What is the current stock price of Codoxo?
Codoxo is a private company, so its shares have no public market price. Caplight tracks Codoxo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Codoxo worth (valuation)?
Valuation information for Codoxo is not publicly available.
Can I buy Codoxo stock?
Codoxo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Codoxo's last funding round?
Codoxo's most recent funding round was Series C on December 17, 2025.
Who are the main investors in Codoxo?
Key investors in Codoxo include Brewer Lane Ventures, Georgia Research Alliance, QED Investors, CVS Health Ventures, TechSquare Labs.
Will Codoxo IPO soon?
No public IPO plans have been announced for Codoxo.
How can I track Codoxo secondary market activity?
Caplight tracks bids, offers, and trades in Codoxo's shares on secondary markets.